These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 33435264

  • 1. In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B.
    Ottanà R, Paoli P, Cappiello M, Nguyen TN, Adornato I, Del Corso A, Genovese M, Nesi I, Moschini R, Naß A, Wolber G, Maccari R.
    Molecules; 2021 Jan 10; 26(2):. PubMed ID: 33435264
    [Abstract] [Full Text] [Related]

  • 2. An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications.
    Maccari R, Del Corso A, Paoli P, Adornato I, Lori G, Balestri F, Cappiello M, Naß A, Wolber G, Ottanà R.
    Bioorg Med Chem Lett; 2018 Dec 15; 28(23-24):3712-3720. PubMed ID: 30342956
    [Abstract] [Full Text] [Related]

  • 3. Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus.
    Kousaxidis A, Petrou A, Lavrentaki V, Fesatidou M, Nicolaou I, Geronikaki A.
    Eur J Med Chem; 2020 Dec 01; 207():112742. PubMed ID: 32871344
    [Abstract] [Full Text] [Related]

  • 4. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
    Jung HA, Islam MN, Lee CM, Oh SH, Lee S, Jung JH, Choi JS.
    Chem Biol Interact; 2013 Oct 25; 206(1):55-62. PubMed ID: 23994501
    [Abstract] [Full Text] [Related]

  • 5. Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B.
    Ottanà R, Paoli P, Lori G, Adornato I, Previti S, Naß A, Wolber G, Maccari R.
    Bioorg Chem; 2019 Nov 25; 92():103211. PubMed ID: 31491569
    [Abstract] [Full Text] [Related]

  • 6. Dual Targeting of PTP1B and Aldose Reductase with Marine Drug Phosphoeleganin: A Promising Strategy for Treatment of Type 2 Diabetes.
    Genovese M, Imperatore C, Casertano M, Aiello A, Balestri F, Piazza L, Menna M, Del Corso A, Paoli P.
    Mar Drugs; 2021 Sep 24; 19(10):. PubMed ID: 34677434
    [Abstract] [Full Text] [Related]

  • 7. Designed multiple ligands for the treatment of type 2 diabetes mellitus and its complications: Discovery of (5-arylidene-4-oxo-2-thioxothiazolidin-3-yl)alkanoic acids active as novel dual-targeted PTP1B/AKR1B1 inhibitors.
    Maccari R, Wolber G, Genovese M, Sardelli G, Talagayev V, Balestri F, Luti S, Santi A, Moschini R, Del Corso A, Paoli P, Ottanà R.
    Eur J Med Chem; 2023 Apr 05; 252():115270. PubMed ID: 36934484
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory activity of Aralia continentalis roots on protein tyrosine phosphatase 1B and rat lens aldose reductase.
    Jung HJ, Jung HA, Kang SS, Lee JH, Cho YS, Moon KH, Choi JS.
    Arch Pharm Res; 2012 Oct 05; 35(10):1771-7. PubMed ID: 23139128
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
    Eleftheriou P, Geronikaki A, Petrou A.
    Curr Top Med Chem; 2019 Oct 05; 19(4):246-263. PubMed ID: 30714526
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors.
    Patel D, Jain M, Shah SR, Bahekar R, Jadav P, Joharapurkar A, Dhanesha N, Shaikh M, Sairam KV, Kapadnis P.
    Bioorg Med Chem Lett; 2012 Jan 15; 22(2):1111-7. PubMed ID: 22189136
    [Abstract] [Full Text] [Related]

  • 17. Discovery of 5-(3-bromo-2-(2,3-dibromo-4,5-dimethoxybenzyl)-4,5-dimethoxybenzylidene)thiazolidine-2,4-dione as a novel potent protein tyrosine phosphatase 1B inhibitor with antidiabetic properties.
    Jiang B, Luo J, Guo S, Wang L.
    Bioorg Chem; 2021 Mar 15; 108():104648. PubMed ID: 33493928
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells.
    Ottanà R, Maccari R, Mortier J, Caselli A, Amuso S, Camici G, Rotondo A, Wolber G, Paoli P.
    Eur J Med Chem; 2014 Jan 15; 71():112-27. PubMed ID: 24287560
    [Abstract] [Full Text] [Related]

  • 19. Design and synthesis of tricyclic terpenoid derivatives as novel PTP1B inhibitors with improved pharmacological property and in vivo antihyperglycaemic efficacy.
    Yang L, Chen F, Gao C, Chen J, Li J, Liu S, Zhang Y, Wang Z, Qian S.
    J Enzyme Inhib Med Chem; 2020 Dec 15; 35(1):152-164. PubMed ID: 31742469
    [Abstract] [Full Text] [Related]

  • 20. Aldose reductase and protein tyrosine phosphatase 1B inhibitory active compounds from Syzygium cumini seeds.
    Sawant L, Singh VK, Dethe S, Bhaskar A, Balachandran J, Mundkinajeddu D, Agarwal A.
    Pharm Biol; 2015 Aug 15; 53(8):1176-82. PubMed ID: 25853967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.